EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploratory Analysis of Circulating miR ‐486‐3p and miR ‐21‐5p in Early Detection and Subtype Classification of Luminal A and B Breast Cancer in Peruvian Women

Desireé Bouroncle iD, Gustavo Colque iD, Luis Huaytalla-Bautista iD, María Claudia Flores-Berrospi iD, Carla Bernal iD, Ivan Belzusarri iD, Jorge Dunstan iD, Mónica Paredes-Anaya iD

Cancer Reports · 2026

DOI: 10.1002/cnr2.70717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Desireé Bouroncle und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genomics and Integrative Biology Laboratory, Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima, Peru. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Biomarkers, Tumor, Early Detection of Cancer. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica, Universidad Nacional Mayor de San Marcos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) remains the most common malignancy among women worldwide, and early detection is essential for improving clinical outcomes. There is a growing need for accessible, minimally invasive molecular biomarkers that complement current diagnostic approaches and support molecular subtype classification.

Aims

This exploratory case–control study evaluated the plasma expression of four circulating miRNAs (miR‐21‐5p, miR‐486‐3p, miR‐451a, and miR‐660‐5p) in Peruvian women with Luminal A ( n = 32) and Luminal B ( n = 43) breast cancer and healthy controls ( n = 36). Methods and Results Expression levels were quantified by qPCR, and diagnostic performance was assessed using logistic regression with leave‐one‐out cross‐validation (LOOCV). miR‐486‐3p was significantly upregulated in Luminal A compared with both controls and Luminal B, whereas miR‐21‐5p was downregulated relative to controls. After validation, miR‐486‐3p retained moderate discriminative ability for distinguishing Luminal A from controls (AUC = 0.651; 95% CI: 0.461–0.841; p = 0.120), while the combined miR‐486‐3p/miR‐21‐5p model showed moderate discriminatory performance for differentiating Luminal A from Luminal B (AUC = 0.690; 95% CI: 0.466–0.914; p = 0.0959). Exploratory functional enrichment analyses suggested that experimentally validated targets of these miRNAs were associated with cancer‐ and immune‐related pathways, providing biological context for their potential roles in breast cancer.

Conclusion

These findings provide preliminary evidence supporting the potential of circulating miR‐486‐3p and miR‐21‐5p as candidate non‐invasive biomarkers for future early detection and molecular subtype classification of Luminal breast cancer. However, these findings should be interpreted cautiously and require validation in larger, independent cohorts before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsBiomarkers, TumorEarly Detection of CancerHumansFemalePeruCase-Control StudiesMiddle AgedAdultGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

biomarkersbreast cancerluminal Bluminal amiR‐21‐5pmiR‐486‐3pmicroRNAstarget genes

Substanzen

MicroRNAsBiomarkers, TumorMIRN21 microRNA, humanMIRN486 microRNA, human

Autor:innen und Institutionen

  • Genomics and Integrative Biology Laboratory, Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Department of Radiotherapy, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Department of Breast and Soft Tissue Surgery, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.

ORCID-Profile: Desireé Bouroncle, Gustavo Colque, Luis Huaytalla-Bautista, María Claudia Flores-Berrospi, Carla Bernal, Ivan Belzusarri, Jorge Dunstan, Mónica Paredes-Anaya

Förderung

  • Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
  • Universidad Nacional Mayor de San Marcos

Zitieren

APA

Bouroncle, D., Colque, G., Huaytalla-Bautista, L., Flores-Berrospi, M. C., Bernal, C., Belzusarri, I., Dunstan, J., & Paredes-Anaya, M. (2026). Exploratory Analysis of Circulating miR ‐486‐3p and miR ‐21‐5p in Early Detection and Subtype Classification of Luminal A and B Breast Cancer in Peruvian Women. Cancer Reports. https://doi.org/10.1002/cnr2.70717

Vancouver

Bouroncle D, Colque G, Huaytalla-Bautista L, Flores-Berrospi MC, Bernal C, Belzusarri I, et al. Exploratory Analysis of Circulating miR ‐486‐3p and miR ‐21‐5p in Early Detection and Subtype Classification of Luminal A and B Breast Cancer in Peruvian Women. Cancer Reports. 2026. doi:10.1002/cnr2.70717

BibTeX
@article{Bouroncle2026,
  author = {Bouroncle, Desireé and Colque, Gustavo and Huaytalla-Bautista, Luis and Flores-Berrospi, María Claudia and Bernal, Carla and Belzusarri, Ivan and Dunstan, Jorge and Paredes-Anaya, Mónica},
  title = {Exploratory Analysis of Circulating miR ‐486‐3p and miR ‐21‐5p in Early Detection and Subtype Classification of Luminal A and B Breast Cancer in Peruvian Women},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70717}
}
Kostenlos starten →